Breathing Life Into Artificial Intelligence*

Hari Trivedi,Judy Gichoya
DOI: https://doi.org/10.1097/ccm.0000000000006124
IF: 8.8
2024-01-20
Critical Care Medicine
Abstract:Recent years have seen an explosion in healthcare artificial intelligence (AI) with radiology-based AI leading the way ( 1 , 2 ). To date in the United States, there are over 390 Food and Drug Administration-cleared AI software devices with even larger numbers in Europe and Asia ( 3 ). The power of AI in aiding detection and diagnosis has been shown in a multitude of retrospective and a few prospective trials; however, good model performance does not always translate to clinical utility ( 4 , 5 ). Careful consideration is required to determine how AI models are deployed into clinical workflow, including the intended recipient and the timeliness and impact of these results on clinical care. With the recent advent of foundation models ( 6 ), the barrier to developing well-performing models in laboratory conditions will continue to decrease model impact and will be governed by careful planning around deployment, safety, and monitoring rather than absolute performance metrics.
critical care medicine
What problem does this paper attempt to address?